HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.

AbstractOBJECTIVE:
To compare the effect of early extubation to nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) on the need for mechanical ventilation via endotracheal tube (MVET) at 7 days of age in preterm infants <30 weeks' gestation requiring intubation and surfactant for respiratory distress syndrome (RDS) within 60  min of delivery.
STUDY DESIGN:
Multicenter, randomized, controlled trial. A total of 57 infants were randomized within 120  min of birth to NCPAP (BW 1099 g and GA 27.8 weeks) and 53 infants to NIPPV (BW 1052  g, and GA 27.8 weeks). Infants were stabilized on NCPAP at birth and were given poractant alfa combined with MVET within 60  min of age. When stabilized on MVET, they were extubated within the next hours or days to NCPAP or NIPPV.
RESULT:
A total of 42% [corrected] of infants needed MVET at 7 days of age in the NCPAP group compared with 17% in the NIPPV group (OR: 3.6; 95% CI: 1.5, 8.7). Days on MVET were 12 ± 11 days in NCPAP group compared with 7.5 ± 12 days in the NIPPV group (median 1 vs 7 days; P=0.006). Clinical bronchopulmonary dysplasia (BPD) was 39% in the NCPAP group compared to 21% in the NIPPV group (OR: 2.4; 95% CI: 1.02, 5.6). Physiological BPD was 46% in the NCPAP group compared with 11% in the NIPPV group (OR: 6.6, 95% CI: 2.4, 17.8; P=0.001). There were no differences in any other outcomes between the two groups.
CONCLUSION:
NIPPV compared with NCPAP reduced the need for MVET in the first week, duration of MVET, and clinical as well as physiological BPD in preterm infants receiving early surfactant for RDS.
AuthorsR Ramanathan, K C Sekar, M Rasmussen, J Bhatia, R F Soll
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 32 Issue 5 Pg. 336-43 (May 2012) ISSN: 1476-5543 [Electronic] United States
PMID22301528 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Pulmonary Surfactants
Topics
  • Continuous Positive Airway Pressure (methods)
  • Female
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Intermittent Positive-Pressure Ventilation (methods)
  • Intubation, Intratracheal (statistics & numerical data)
  • Male
  • Pregnancy
  • Prospective Studies
  • Pulmonary Surfactants (therapeutic use)
  • Respiration, Artificial (methods, statistics & numerical data)
  • Respiratory Distress Syndrome, Newborn (diagnosis, mortality, therapy)
  • Risk Assessment
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: